Diphenoxylate/atropine
Revision as of 14:49, 14 September 2019 by ClaireLewis (talk | contribs)
Administration
- Type: Antidiarrheal, opioid analog/anticholinergic
- Dosage Forms:
- Routes of Administration: PO
- Common Trade Names: Lomotil
Adult Dosing
- 5 mg diphenoxylate/0.05 mg atropine PO q6hr
Pediatric Dosing
- <2y: Safety/efficacy not established
- 2-13y: 0.3-0.4 mg diphenoxylate/kg/day in 4 divided doses
Special Populations
Pregnancy Rating
- Category C
Lactation risk
- "Exercise caution when drug is administered to nursing woman, since physicochemical characteristics of major metabolite, diphenoxylic acid, are such that it may be excreted in breast milk and since it is known that atropine is excreted in breast milk"[1]
Renal Dosing
- Use caution
Hepatic Dosing
- Use caution; may precipitate hepatic coma
Contraindications
- Allergy to class/drug
- Obstructive jaundice
- Diarrhea due to pseudomembranous enterocolitis or infectious enterotoxin-producing bacteria (e.g. c. diff)
- Tablets only: children age <6y (risk of respiratory/CNS depression)
- Concomitant MAOI therapy
Adverse Reactions
Serious
- Severe respiratory depression
- Coma
- Exacerbation of dehydration and electrolyte imbalances due to intestinal fluid retention secondary to inhibition of peristalsis
- Bacterial overgrowth, release of bacterial endotoxins, sepsis
- Toxic megacolon
- Anticholinergic toxicity (hyperthermia, tachycardia, urinary retention, flushing, dry skin/mucous membranes), particularly in pediatric patients with Down's syndrome
- Pancreatitis
Common
- Nausea/vomiting, abdominal discomfort
- Blurred vision
- Sedation
- Dry skin or mouth
Pharmacology
- Half-life: 2.5-14h
- Metabolism: Hepatic
- Excretion: Urine/feces
Mechanism of Action
- Diphenoxylate: opioid analog of meperidine, inhibits GI motility and excessive GI propulsion
- Atropine: Subtherapeutic quantity added to discourage deliberate overdose of diphenoxylate